Login / Signup

Selective optogenetic inhibition of Gα q or Gα i signaling by minimal RGS domains disrupts circuit functionality and circuit formation.

Jayde L LockyerAndrew ReadingSilvia VicenziAgnieszka ZbelaSaranya ViswanathanCaroline DelandreJake W NewlandJohn P D McMullenOwen J MarshallRobert GasperiniLisa FoaJohn Y Lin
Published in: Proceedings of the National Academy of Sciences of the United States of America (2024)
Optogenetic techniques provide genetically targeted, spatially and temporally precise approaches to correlate cellular activities and physiological outcomes. In the nervous system, G protein-coupled receptors (GPCRs) have essential neuromodulatory functions through binding extracellular ligands to induce intracellular signaling cascades. In this work, we develop and validate an optogenetic tool that disrupts Gα q signaling through membrane recruitment of a minimal regulator of G protein signaling (RGS) domain. This approach, Photo-induced Gα Modulator-Inhibition of Gα q (PiGM-Iq), exhibited potent and selective inhibition of Gα q signaling. Using PiGM-Iq we alter the behavior of Caenorhabditis elegans and Drosophila with outcomes consistent with GPCR-Gα q disruption. PiGM-Iq changes axon guidance in cultured dorsal root ganglia neurons in response to serotonin. PiGM-Iq activation leads to developmental deficits in zebrafish embryos and larvae resulting in altered neuronal wiring and behavior. Furthermore, by altering the minimal RGS domain, we show that this approach is amenable to Gα i signaling. Our unique and robust optogenetic Gα inhibiting approaches complement existing neurobiological tools and can be used to investigate the functional effects neuromodulators that signal through GPCR and trimeric G proteins.
Keyphrases
  • spinal cord
  • type diabetes
  • traumatic brain injury
  • metabolic syndrome
  • oxidative stress
  • endothelial cells
  • zika virus
  • spinal cord injury
  • brain injury
  • drug induced